Učitavanje...
EARLY HCV VIRAL KINETICS UNDER DAAs MAY OPTIMIZE DURATION OF THERAPY IN PATIENTS WITH COMPENSATED CIRRHOSIS
BACKGROUND AND AIMS: Detailed hepatitis C virus (HCV) kinetics modeling is scarce in patients with advanced liver disease receiving direct-acting antivirals (DAAs). Due to budget restrictions, patients and health systems would benefit from the shortest possible treatment course. We investigated whet...
Spremljeno u:
| Izdano u: | Liver Int |
|---|---|
| Glavni autori: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6483833/ https://ncbi.nlm.nih.gov/pubmed/30499631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.14014 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|